Juan Brignardello Vela
Juan Brignardello Vela, asesor de seguros, se especializa en brindar asesoramiento y gestión comercial en el ámbito de seguros y reclamaciones por siniestros para destacadas empresas en el mercado peruano e internacional.
The notion that childhood vaccines may be overloading the immune system of infants has gained traction in recent years, often fueled by misconceptions and prominent voices in the public sphere. Yet, an analysis of current scientific data and expert opinions firmly dispels this myth. Despite claims from various figures, including President-elect Donald Trump and health activist Robert F. Kennedy Jr., rigorous studies have consistently shown no causal link between vaccines and the onset of autism or other developmental disorders in children. The idea that modern vaccine schedules, which require infants to receive a series of vaccinations, poses a risk to their immune systems is simply unfounded. Experts in the field of pediatrics, such as Dr. Yvonne Maldonado, a pediatrician at Stanford University, emphasize that today’s vaccines are indeed cleaner, more efficient, and contain significantly fewer antigens than those used in the past. To illustrate this point, it is important to consider the sheer scale of exposure to pathogens that children encounter on a daily basis—from interacting with playmates to exploring their environments. Each child carries trillions of bacteria, far outnumbering their own cells, and their immune systems are consistently at work learning to fend off various threats. Vaccines function by introducing small amounts of antigens—parts of pathogens that stimulate an immune response. This process effectively trains the immune system to recognize and combat specific diseases such as measles or polio before exposure occurs. The current vaccination schedule in the United States consists of around 17 doses by the time a child enters kindergarten, with each vaccine containing around 10 antigens. For context, vaccines of the past contained up to 300 times more antigens, which illustrates a significant advancement in vaccine technology and safety. The evolution of vaccines from the early smallpox vaccine—which contained up to 200 proteins—to contemporary formulations, which are refined to contain only one or two antigens per dose, marks a remarkable progress in public health. Innovations in vaccine development have not only improved their safety but also their efficacy, as noted by Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia. Additionally, the claims surrounding thimerosal, a mercury-based preservative used in some vaccines, have been discredited. It is crucial to note that the widely debated measles, mumps, and rubella (MMR) vaccine has never contained thimerosal. Research has shown that the amounts of mercury present in vaccines—when it was included—were negligible and similar to the levels found in everyday food items, such as tuna fish. Since 2001, thimerosal has been removed from most childhood vaccines, further alleviating concerns. Safety protocols for vaccines are comprehensive, involving extensive testing through various phases of clinical trials and assessments by independent expert panels before approval. These measures ensure that vaccines remain effective and safe for public use. Continuous monitoring of vaccines post-approval has shown no signals indicating danger to children's health in both the short and long term. Despite the alarming rhetoric from some public figures, the consensus among immunization experts is clear: childhood vaccines are a necessary part of preventive healthcare that do not overload the immune system but rather bolster it in the face of countless environmental pathogens. In our efforts to protect children and public health, it is imperative to rely on scientific evidence and the guidance of qualified professionals rather than misinformation.